Colorectal cancer (CRC) is a classic example of a tumor that progresses through multiple distinct stages in its evolution. To understand the mechanisms regulating the transition from indolent to invasive disease, we profiled somatic copy number alterations in non-invasive adenomas and invasive adenocarcinomas from Apc and DNA mismatch repair (MMR) mutant mouse models. We identified a recurrent amplicon on mouse chromosome 8 that encodes microRNAs (miRs) 23a and 27a. miRs-23a and 27a levels are upregulated in mouse intestinal adenocarcinomas, primary tumors from stage I/II CRC patients, as well as in human CRC cell lines and cancer stem cells. Functionally,
INTRODUCTION

Colorectal cancer (CRC) is the 2nd leading cause of cancer death in the United
States (1) . CRC is a classic example of a tumor that progresses through multiple distinct stages in its evolution. Mutations activating WNT (most often APC) and KRAS pathways occur as an early event in cancer cells (2, 3) . Subsequently, mutations in TGF-ȕ, PI3-Kinase, TP53 pathways, DNA mismatch repair genes (MMR), FBXW7 and others accumulate in these long lived cells (4, 5) . Morphologically, inappropriate proliferation causes formation of adenomas. Adenomas progress to carcinoma in situ and early stage CRCs. This process typically lasts several years (6, 7) . Then, in a relatively short time early stage CRCs acquire the ability to invade through the colon wall, metastasize, and survive outside the colon niche microenvironment (6, 7). As 5 year survival for indolent CRC is ~90% vs. 10-15% for metastatic CRC, understanding the mechanisms that regulate the transition from indolent adenomas and carcinoma in situ to invasive and metastatic CRC is critical to improving patient outcomes (8) .
MicroRNAs (miRs) are small, endogenous non-coding RNAs that simultaneously regulate levels of multiple proteins, primarily by binding to the 3' UTR of targets and inhibiting protein translation (9) . Important roles for miRs have been demonstrated in multiple types of cancer, including roles in tumor progression by modulating single primary transcript but the levels of each can vary because of post-transcriptional processing (i.e. levels of one or two of these miRs can increase while the third does not) (12) .
Previously, we described a mouse model system to study the mechanisms regulating the transition from pre-invasive to invasive intestinal/colon tumors (14) . MTSS1 interacts directly with cortactin to promote filopodia formation and upregulates SRC signaling (17) . Reduced MTSS1 levels promote CRC cell and cancer stem cell migration, invasion and metastasis. In vivo, miR-27a is required for subcutaneous CRC cell xenograft (18, 19) tumor growth, and both miR-23a and 27a are required for formation of hematogenous metastases. Computational analyses of publically available CRC gene expression profiling datasets are consistent with a role for miR-23a, but not miR-27a, specifically in invasive CRC. Overall, these data support a potential mechanistic role for miR-23a and its target genes in the transition from indolent to invasive CRC.
Research.
on 
RESULTS
High Resolution Tiling Array Profiling of Mouse Intestinal Adenomas and Adenocarcinomas
To investigate the mechanisms that cause progression of intestinal adenomas to adenocarcinomas, we performed high-resolution tiling array based somatic copy number profiling of mouse chromosomes 6, 7,8 and 9 in Apc -/-;MMR-deficient adenocarcinomas vs. MMR-deficient adenomas, which we had previously shown using array comparative genomic hybridization to contain amplified loci (14) . This identified a recurrent 5MB amplicon on mouse chromosome 8 with increased copy number in Apc (Fig. 1E) . miR-27a expression levels were higher in both comparisons of either stage I/II or III/IV CRCs vs. pre-invasive colon adenomas and carcinoma in situ (Fig. 1F) . In summary, the human CRC and mouse intestinal tumor expression data are consistent with potential roles for miR-23a and 27a in CRC progression from pre-invasive to locally invasive and metastatic disease. Importantly, miR-23a expression is specifically higher in CRCs from patients with locally invasive (stage I/II) disease.
MicroRNA Profiling Reveals High Endogenous Levels of miRs 23a and 27a in Colon Cancer Stem Cells and Commonly Used Colon Cancer Cell Lines
Research. Recent studies have highlighted the important role of colon cancer stem cells (CCSC) in CRC progression and metastasis (20) . CCSC have high tumorigenicity and self-renewal capacity and are often found at the leading edge of invasive CRCs. CCSC are also proposed to play critical roles in seeding extra-colonic metastases. To understand the roles of miRs 23a and 27a in CCSC, we performed LNA-microarray based microRNA profiling of CCSC. MicroRNA profiling of CCSC showed that both miR23a and miR-27a are among the most highly expressed miRs in CCSC, consistent with potential functional roles ( Fig. 1G ; Supplemental Table S1 ). We also tested several commonly used non-CCSC CRC cell lines for miR-23a and miR-27a expression and found that both microRNAs were highly expressed (Supplemental Fig. S3A ). Overall, these data confirm mouse intestinal tumor and human CRC data and show that miRs 23a and 27a are highly expressed in both CCSC and non-CCSC CRC cell lines. There was no difference between expression levels of miR-23a or 27a in CRC patient MMRproficient vs. deficient tumors (data not shown).
FBXW7 Is a Direct miR-27a Target
We used computational target prediction algorithms (21) (22) (23) (24) to identify miR-27a target genes, with putative miR-27a binding motifs in their 3'UTRs. One of the targets shared by all algorithms tested included F-box and WD repeat domain-containing 7 (FBXW7), which is mutated in 6-9% of CRCs (25) (26) (27) . FBXW7 encodes an ubiquitin ligase that regulates proteasomal degradation of binding substrates (15, 16, 25) .
FBXW7 is a key regulator of several signaling pathways, including NOTCH, MYC and JUN (16) , and FBXW7 mutation stimulates cell proliferation (16 site in the FBXW7 3'-UTR (nucleotides 502-508 and 1378-1384) ( Fig. 2A, top) is highly conserved in different species. Using a luciferase reporter construct expressing the FBXW7 3'-UTR, we confirmed that FBXW7 is a direct target of miR-27a ( Fig. 2A,   bottom) . We then used a lentiviral construct expressing anti-miR-27a and infected CRC cell lines and CCSCs. Western blot analysis confirmed that miR-27a knockdown significantly increases FBXW7 levels vs. control shRNA transduced cells (Fig. 2B) .
Altogether, these data are consistent with FBXW7 as a direct target of miR-27a. substrates (Fig. 2C) (28, 29) . To test whether miR-27a regulates these downstream targets, we used lentiviral anti-miR-27a knockdown in CCSC (Supplemental Fig. S3B ), which have active MYC, JUN and NOTCH signaling (20, 30) . Compared with lentiviral expression of a control scrambled sequence shRNA, lentiviral miR-27a knockdown reduced protein levels of FBXW7, JUN and MYC. Similarly, phosphorylated c-JUN and c-MYC were also reduced, consistent with downregulated JUN and MYC signaling (Fig.   2B ).
miR-27a
Next, we evaluated whether miR-27a knockdown in CCSC impairs NOTCH signaling. The downstream canonical NOTCH pathway target genes HES1 and HES5 are upregulated by active NOTCH signaling (31) . Consistent with miR-27a upregulation of NOTCH signaling, CCSC with miR-27a knockdown had lower HES1 and HES5 levels than control cells (Fig. 2D) and shRNA knockdown (Supplemental Fig. S3B and S3C ). Both experimental approaches showed that lowering miR-27a levels consistently and significantly inhibited CCSC proliferation ( Fig. 3A; Supplemental Fig. S3D ). By comparison, miR-23a knockdown had a more modest effect on cell proliferation (Supplemental Fig. S4A ).
miR-27a knockdown also significantly impaired CCSC clonogenicity, while the impact of miR-23a knockdown had less effect ( growth (P=0.0004) (Fig. 3D-F) . In contrast, miR-23a knockdown in CCSC did not significantly cause a reduction in xenograft tumor volume (Supplemental Fig. S4C ).
miR-27a Overexpression In Vitro Promotes Cell Growth and Proliferation in DLD1 Cells
To understand in more detail its mechanistic role, we used lentiviral infection to express constitutively miR-27a in the DLD1 CRC cell line, which has low endogenous levels (Supplemental Figure S5 ranking predicted target was Metastasis suppressor 1(MTSS1); (also known as missing in metastasis, MIM, or BEG4) a recently identified actin-binding protein (17, 19, 32) . The MTSS1 3'-UTR contains a putative miR-23a binding site (nt 1949-1955 ) that is highly conserved across multiple species (Fig. 4D, top) . Using a luciferase reporter construct expressing the MTSS1 3'-UTR, we confirmed that MTSS1 is a direct target of miR-23a (Fig. 4D, bottom) . Next, using Western blotting we showed that miR-23a knockdown in CCSC significantly increases MTSS1 levels vs. control shRNA transduced cells (Fig.   4E ).
MTSS1 is expressed in several embryonic tissues including the developing central nervous system [20] . There, MTSS1 interacts with SRC and cortactin to inhibit cell migration (33) . Also consistent with a role in cell motility, MTSS1 is downregulated in several metastatic cancer cell lines (18, 34) . Cell migration is accomplished by the formation of cellular protrusions including lamellipodia and filopodia (35) . These protrusions result from actin filament (F-actin) rearrangement at the cell cortex by WASP/WAVE, RHO family proteins and other factors (35) , which is an important mechanism for enabling cell motility. Small RHO family GTPases including CDC42, RAC, and RHO control the formation and extension of filopodia, lamellipodia, de novo actin polymerization and enable cell migration (36) (37) (38) .
When plated onto laminin coated chamber slides, CCSC attach and extend filopodia along the surface. In contrast, CCSC with miR-23a knockdown do not attach well to laminin-coated plates ( RHOB is a mainly endosomal small GTPase that regulates actin organization, vesicle trafficking and RHO/RAC signaling. In multiple types of cancer cells, RHOB inhibits cellular invasion, and metastasis, and during malignant progression RHOB levels decrease (39) . Because MTSS1 has been shown to directly affect RHO/RAC signaling (40), we assayed CCSC with lentiviral miR-23a knockdown for RHOB protein levels and RAC1 activity. CCSC with miR-23a knockdown and increased MTSS1 levels vs. control knockdown cells had increased levels of RHOB and reduced RAC1 activity ( Fig. 5D and E), consistent with impaired cell motility.
MTSS1 has also been shown to regulate actin cytoskeleton dynamics and interact with cortactin (CTTN), a key substrate of the oncogenic SRC kinase and a major activator of actin branching and polymerization (41, 42) . Consistent with a role for miR23a regulation of MTSS1 and downstream inhibition of activated SRC, p-SRC (Thr416), is decreased in the miR-23a knockdown CCSC (Fig. 5F ). In sum, these data are consistent with a mechanism whereby miR-23a downregulates MTSS1, which decreases RHOB and increases RAC1 and SRC activity. This in turn causes F-actin dysregulation and filopodia extension, which upregulates migration and invasion by CCSC and non-CCSC CRC cell lines. S5 ). Similar to miR-27a overexpression studies, we used a lentiviral vector to overexpress miR-23a in DLD1 cells. DLD1 cells expressing high miR-23a levels showed a significant increase in migration and invasion ability as compared to the control cells (Supplemental Fig.   S7A-C) . Overall, these data are complementary to miR-23a shRNA knockdown studies and consistent with a role for miR-23a to promote migration and invasion.
miR-23a and miR-27a Inhibit CCSC Tumor Formation in a Mouse Model of Metastasis
Hematogenous injection of cells into the tail vein of immunodeficient mice is a commonly used in vivo assay of metastasis. We used this system to study the roles of miRs-23a and 27a in metastasis using CCSC expressing anti-miR-23a, anti-miR-27a or a control shRNA. Both miR-23a and miR-27a knockdown resulted in significantly fewer lung tumors vs. control CCSC (Fig. 6A-D) . Also consistent with inhibition of metastatic tumor formation, knockdown of either miR-23a or 27a significantly increased overall survival of mouse hosts vs. cells expressing the control shRNA ( Fig. 6E and F) . In summary, these results are consistent with important in vivo roles for miR-23a and miR27a in metastatic tumor formation. For miR-27a, the data are consistent with a mechanism of promoting cell proliferation, and for miR-23a a mechanism primarily caused by increased cell motility. Table S2 and Supplemental Fig. S8A-B) shows the distribution of the permuted test statistic of miR23a and miR-27a in dataset GSE14333 from 10000 times permutation of samples. 
DISCUSSION
Understanding the molecular mechanisms that regulate the transition from preinvasive to invasive CRC is critical to the development of novel approaches to arrest tumor progression and improve CRC patient outcomes. Here, we describe roles for miRs 23a and 27a in mechanisms that are associated with tumor progression.
Importantly, both functional and patient CRC expression analyses are consistent with potentially important roles for miR-23a specifically to stimulate migration, invasion and promote the transition from indolent to invasive CRC. of the colon goblet cell marker MUC2. Overall, these data are consistent with roles for miR-27a to promote general mechanisms associated with tumor progression. However, analysis of predicted miR-27a target gene expression levels in publically available large scale gene expression datasets show upregulation of predicted targets in primary CRCs from patients with late vs. early stage disease even though miR-27a levels do not decrease. While there are clearly many potential confounding factors that could cause this discrepancy (e.g. the lack of information in these datasets on which patients did or did not receive chemotherapy, cross-regulation by other microRNAs, stochastic noise, etc.), altogether they limit the specific conclusions that can be drawn at present about the role of miR-27a specifically in CRC patient tumor progression. Again, as genome wide datasets comparing pre-invasive to invasive CRC become available it will be important to investigate in more detail the potential role of miR-27a to promote the transition from pre-invasive to invasive CRC, as well as in other tumor types. 
METHODS
Mice
All animal studies were performed under an approved Weill Cornell IACUC protocol. ; Pms2 -/-mice have all been described previously and were maintained on the C57B/L6 genetic background (50) . All lines of mice were necropsied when they became morbid or moribund.
Sacrificed mice were surveyed for tumors and suspicious masses.
Mouse Tiling Array Studies
Genomic DNA was isolated from tumor and normal tissue from each mouse using the PUREGENE DNA Isolation kit (Gentra Systems, Minneapolis, MN). Nimblegen tiling array hybridization of mouse chromosomes 6-9 were performed at NimbleGen Systems Array data were analyzed using the SignalMap Software version 1.8 (NimbleGen Systems Inc.).
MicroRNA Isolation and qRT-PCR
MicroRNA was extracted from cell lines and tissues using mirVANA spin columns (Ambion, Austin, TX, USA). All primary CRC tissues in this study were taken from 
RNA Isolation and qRT-PCR
Total RNA was extracted using the Qiagen RNeasy kit and reverse transcribed using the ABI Reverse Transcription Kit. Gene expression was quantified on a BioRad realtime PCR analyzer (CFX96). Expression levels are the average of three or more independent experiments. All expression levels are normalized to GAPDH mRNA levels.
Culture of CCSC and Colon Cancer Cell Lines
CCSC lines used in this study are established cell lines from human colon cancer resections generated by our laboratory and have been described previously (19) . CCSC were cultured in vitro in ultra-low attachment flasks with DMEM/F12 containing nonessential amino acids, antibiotic-antimycotic, N2 supplement (Invitrogen), B27 supplement (Invitrogen), heparin 4ug/ml (Sigma), EGF (40ng/ml), bFGF (20ng/ml) at 37°C at 5% CO 2 , essentially as previously described (19) . CCSC lines were authenticated by KRAS, BRAF and SNP genotyping. polybrene at 8ug/ml for 8h. The media was replaced with fresh media containing 2 ug/ml of puromycin, essentially as previously described (20) .
Cell Viability Assays
Viability of cells was measured by using the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction method. Cells at a density of 3.0 × 10 3 /well were seeded into 96-well dishes in triplicate for each independent experiment. Cells were incubated with 2.5% MTT solution (5 mg/ml) for 3.5 h at 37 °C.
DMSO was then used to dissolve the formazan product for spectrophotometric analysis at 540 nm.
Cell Migration, Invasion, and Clonogenicity Assays
To assay cell migration, the Boyden chamber assay was used. 1 × 10 5 of CCSC were seeded onto fibronectin-coated polycarbonate membrane inserts (6.5 mm in diameter with 8.0 ȝm pores) in a transwell apparatus (Costar) and cultured in CCSC media. 5% FBS was added to media in the lower chamber. After incubation for 12h at 37 °C in a CO 2 incubator, the insert was washed with PBS and cells on the top surface of the insert were removed by wiping with a cotton swab. Cells were then fixed with methanol, stained with 0.4% crystal violet solution and inspected microscopically at 
chosen fields were counted. Clonogenicity assays were performed essentially as previously described (20) . The value for each assay represents the mean ± SEM of triplicate measurements from at least 3 independent experiments.
Protein Isolation and Western blotting
CCSC spheres and cell pellets were lysed in ice cold NP40 lysis buffer (50mM TrisHCl, pH7.5, 150mM NaCl, 1mM EDTA and 1% NP-40). Protein quantification was carried out using Bio-Rad protein quantification assay. Proteins were separated by SDS/PAGE and transferred to Immobilon-P PVDF (Millipore). Membranes were blocked with 5% nonfat dry milk and incubated overnight at 4°C with the indicated primary antibody. Detection was carried out by peroxidase based chemiluminescence (Amersham). Antibodies used are listed in Supplemental Methods.
Immunohistochemistry
Immunohistochemistry was performed on 5μM paraffin embedded sections from 3D Matrigel cultures as previously described (20) . Paraffin embedded sections were deparaffinized in xylene and rehydrated in a graded alcohol series and water. The slides were heated in antigen retrieval solution and incubated with Anti-Myc-tag (1:500) or Anti-Muc2 (1:250) antibodies overnight at 4 °C. The ABC kit (Vector) was used to visualize antigen. Counter staining was done using hematoxylin. Immunofluorescence was performed on CCSC grown on laminin coated chamber slides that had been fixed 
100 for 2-10 minutes. Chamber slides were then stained with Alexa Fluor 488® phalloidin at a dilution of 1:250 and analyzed with fluorescence microscopy.
Subcutaneous Xenograft Assay
NOD/SCID (NOD) mice were obtained from the Jackson Labs (ME). All animals used were between 6 and 8 weeks of age and housed in micro-isolator cages in 
miRCURY LNA™ microRNA Array Studies
Total RNA was extracted using the Qiagen RNeasy kit. MicroRNA profiling was performed at Exiqon (Vedbaek, Denmark). The hybridization was performed according to the miRCURY™ LNA array manual using a Tecan HS4800 hybridization station. After hybridization, the microarray slides were scanned and stored in an ozone-free environment (ozone level below 2.0 ppb) to prevent potential bleaching of the fluorescent dyes. The miRCURY™ LNA array microarray slides were scanned using the Agilent G2565BA Microarray Scanner System (Agilent Technologies, Inc., USA) and the image analysis was carried out using the ImaGene 8.0 software (BioDiscovery, Inc., USA).
Clinical CRC Gene Expression Microarray Dataset Analyses
To compare the expression of miR-23a and miR-27a 
